Brazilian Journal of Psychiatry
November 21, 2018
Flávia S. Da Silva, Erick Allan Dos Santos Silva, Geovan Menezes de Sousa et al.
46 citations
In a juvenile marmoset model of depression, a single dose of ayahuasca reversed stress-induced hypocortisolemia within 24 hours, reduced stereotypic scratching in males, increased feeding in males, and restored body weight in both sexes, with behavioral effects lasting up to 14 days. Saline vehicle did not produce these effects. The findings suggest ayahuasca may have rapid and sustained antidepressant properties, supporting further research into psychedelics for early-onset depression.
Frontiers in Behavioral Neuroscience
June 11, 2021
Maria Bernardete Cordeiro de Sousa, Maria Lara Porpino de Meiroz Grilo, Nicole Leite Galvão‐coelho
7 citations
Marmosets, studied in their natural habitat using non-invasive fecal hormone measurements, are mainly monogamous, live in stable social groups with female competition and male cooperation, and form social bonds similar to humans, making them a potential model for social stress disorders. Laboratory studies confirm these behaviors and show sexually dimorphic responses to challenges influenced by age and social context. Their good adaptation to captivity, twin births, small size, and life cycle advantages have led to their use as animal models for psychiatric diseases like major depression. Juvenile marmosets have been used to develop a depression model and test Ayahuasca as an alternative treatment, with positive results encouraging further studies.
bioRxiv (Cold Spring Harbor Laboratory)
January 25, 2018
Flávia Santos Da Silva, Erick Allan Dos Santos Silva, Geovan Menezes de Sousa et al.
4 citations
preprint
In a juvenile model of depression using common marmosets, a single dose of ayahuasca reversed depressive-like symptoms within 24 hours, including recovery of cortisol levels, reduced stereotypic scratching in males, increased feeding, and restored body weight in both sexes. The effects lasted 14 days. The study suggests ayahuasca produces faster and more durable antidepressant effects than the tricyclic antidepressant nortriptyline, supporting its potential as a treatment for early-age depression.